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ABSTRACT
Two  simple  and  cost  effective  spectrophotometric  methods  were  described  for  the  determination  of  Doripenem  and 
Ertapenem  in  pure  form  and  in  pharmaceutical  formulations.  The  method  is  based  on  the  formation  of  blue  colored 
chromogen  when  the  drug  reacts  with  Folin-Ciocalteu  (F-C)  reagent  in  alkaline  medium.  The  colored  species  has  an 
absorption maximum at 725 nm for Doripenem (Method A); 848 nm for Ertapenem (Method B) and obeys beer’s law in the 
concentration range 0.02-0.1 mg/mL for both Doripenem and Ertapenem. The apparent molar absorptivities were 1.26×10
-5, 
7.86×10
-6 and  sandell’s  sensitivity  was  6×10
-4 respectively  for  Doripenem  and  Ertapenem.  The  slopes  were  0.3371  ± 
0.01245,  0.2611 ±  0.004327 and intercept  of the  equation of the  regression  line  are  0.02857 ±  0.01885,  -0.008095 ± 
0.006550 for Doripenem and Ertapenem respectively. The optimum experimental parameters for the reaction have been 
studied and the validity of the described procedure was assessed. Statistical analysis of the results has been carried out 
revealing  high  accuracy  and  good  precision.  The  proposed  method  was  successfully  applied  for  the  determination  of 
Doripenem and Ertapenem in pharmaceutical formulations.
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INTRODUCTION
Doripenem 
[1] (common name doripenem monohydrate) is an 
ultra-broad spectrum injectable antibiotic. It is a beta-lactam 
antibiotic and belongs to the subgroup of carbapenems. It is 
particularly  active  against  Pseudomonas  aeruginosa. 
Chemically it is (4R, 5S, 6S)-6-(1-hydroxyethyl)-4-methyl-7-
oxo-3-[(3S, 5S) - [(sulfamoylamino) methyl] pyrrolidin-3-yl] 
sulfanyl-1-azabicyclo  [3.2.0]  hept-2-ene-2-carboxylic  acid. 
Doripenem  can  be  used  for  bacterial  infections  such  as 
complex abdominal infections, pneumonia within the setting 
of a hospital, and complicated infections of the urinary tract 
including kidney infections with septicemia.
Ertapenem 
[2] is a carbapenem antibiotic marketed by Merck 
as Invanz. It is structurally very similar to meropenem in that 
it possess a 1-β-methyl group. Chemically it is (4R, 5S, 6S)-
3-[(3S, 5S)-5-[(3-carboxyphenyl) carbamoyl] pyrrolidin-3-yl] 
sulfanyl-6-(1  hydroxy  ethyl)-4-methyl-7-oxo-1-azabicyclo 
[3.2.0]  hept-2-ene-2-carboxylic  acid.  Prospective, 
multicenter,  randomized, double-blind, comparative clinical
studies demonstrate similar clinical efficacy of ertapenem 
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compared with other carbapenems.
Fig. 1 : Chemical Structure of Doripenem and Ertapenem
Literature survey revealed that the drugs were determined by 
using  HPLC
[3-8] and some  spectrophotometric  methods.
[9]
According to literature survey there is no method reported for 
these penems with F-C reagent by visible spectrophotometry. 
The  aim of this  study  was to  make an attempt  to develop 
simple  and  sensitive  spectrophotometric  methods  for  the 
estimation of the above named penems in pure drug and in 
pharmaceutical  formulations.  The  method  uses  the  well 
known oxidation reaction involving F-C reagent and penems 
resulting in the formation of a green chromogen that could be 
measured  at  725  nm  for  doripenem  and  848  nm  for 
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Experimental
Apparatus
All  spectral  characteristics  and  absorbance  measurements 
were made on Perkin Elmer, LAMBDA 25 double beam UV-
Visible spectrophotometer with 10 mm matched quartz cells. 
All  chemicals  used  were  of  analytical  reagent  grade  and 
double distilled water was used throughout. F-C reagent 2N 
supplied  by  SD  Fine  chemicals  ltd.,  India,  was  used  by 
diluting  50  mL  to  100 mL  with  distilled  water.  Sodium 
carbonate solution (10%) was prepared by dissolving 10 g of 
sodium  hydroxide  in  100  mL  double  distilled  water.  1
mg/mL stock reference solution was freshly prepared from 
pure sample of doripenem/ertapenem by dissolving 100 mg 
in 100 ml of double distilled water.
General procedure
Method A
Into  10ml  volumetric  flask,  different  aliquots  of  working
standard  solution  (0.5-3.0  mL)  of  Doripenem  were 
transferred to provide final concentration range of 0.02-0.12 
mg/mL. To each flask 2.0 mL of sodium carbonate and 1.0 
mL of F-C reagent were successively added and kept aside 
for  5  min.  The  solutions  were  made  up  to  volume  with 
distilled  water.  The  absorbance  of  each  solution  was 
measured  at  725  nm  against  the  reagent  blank.  The 
calibration  graph  was  then  prepared  by  plotting  the 
absorbance  versus  the  concentration  of  the  drug.  The 
concentration of the unknown was read from the calibration 
graph or computed from the regression equation.
Method B
Into 25 mL volumetric flask, different aliquots of working 
standard solution (0.5-2.5 mL) of Ertapenem were transferred 
to provide final concentration range of 0.02-0.1 mg/mL. To 
each flask, 5 mL of sodium carbonate and 2.0 mL of F-C 
reagent were successively added and kept aside for 5 min. 
The solutions were made up to volume with distilled water. 
The absorbance of each solution was measured at 848 nm 
against  the  reagent  blank.  The  calibration  graph  was  then 
prepared by plotting the absorbance versus the concentration 
of the drug. The concentration of the unknown was read from 
the  calibration  graph  or  computed  from  the  regression 
equation.
Procedure for Injections
A  volume  of  the  injection  equivalent  to  100  mg  of 
Doripenem/Ertapenem  were  weighed  into  a  100  mL 
volumetric  flask,  50  mL  of  distilled  water  was  added  and 
shaken thoroughly for about 10 minutes, then the volume was 
made up to the mark with the distilled water, mixed well and 
filtered.  Further  dilutions  were  made  and  the  assay  of 
injections was completed according to general procedure.
RESULTS AND DISCUSSION
The  F-C  reagent  was  used  in  the  determination  of  many 
phenolic  compounds,  amines  and  a  large  number  of 
substances of pharmaceutical interest. The proposed method 
is  based  on  the  formation  of  a  blue  colored  chromogen, 
following the reduction of phospho-molybdo tungstic mixed 
acids  of  the  F-C  reagent  by  Doripenem/Ertapenem  in  the 
presence of sodium carbonate, which could be measured at 
725 nm and 848 nm respectively. The mixed acids in the F-C 
reagent were the final chromogen and involve the following 
chemical species:
3H2O, P2O5, 13WO3, 5MoO3, 10 H2O
And
3H2O, P2O5, 14 WO3, 4MoO3, 10H2O
Both drugs probably effect reduction of oxygen atoms from 
tungstate  and  /  or  molybdate  in  the  F-C  reagent,  there  by 
producing one or more possible reduced species which have 
characteristic  intense  blue  color.  The  effect  of  different 
variables  such  as  nature  and  strength  of  alkali,  optimum 
volumes of sodium carbonate and F-C reagent, reaction time 
and order of addition of reactants were studied and optimized 
for  attainment  of  maximum  color  and  stability  of  colored 
species.
Optimization of conditions on absorption spectrum of the 
reaction product
The condition under which reaction of both drugs with F-C 
reagent fulfills the essential  requirements was investigated. 
All conditions studied were optimized at room temperature 
(32±2°C).
Selection of reaction medium
To find a suitable medium for the reaction, different aqueous 
bases were used, such as borax, sodium hydroxide, sodium 
carbonate  or  bicarbonate,  sodium  acetate  and  sodium 
hydrogen  phosphate.  The  best  results  were  obtained  when 
sodium  carbonate  was  used.  In  order  to  determine  the 
optimum  concentration  of  sodium  carbonate,  different 
volumes  of  10%  sodium  carbonate  solution  (2.0-7.0  mL) 
were  used  to  a  constant  concentration  of  Doripenem  (1
mg/mL); (3.0-7.0 mL) were used to a constant concentration 
of Ertapenem (1mg/mL) and the results were observed. From 
the absorption spectrum it was evident that 2.0 mL of 10% 
sodium carbonate solution for Doripenem; 5.0 mL of 10% 
sodium  carbonate  solution  for  Ertapenem  were  found 
optimum.  Larger  volumes  had  no  significant  effect  on the 
absorbance of the colored species.
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Fig. 2 : Calibration graph of Doripenem
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Effect of order of addition of reactants
Few trials were performed to ascertain the influence of order 
of  addition  of reactants  on  the  color  development and  the 
results  are  presented  in  Table  1.  The  order  of  addition  of 
serial number (i) is recommended for both Doripenem and 
Ertapenem.
Effect of F-C reagent concentration
Several experiments were carried out to study the influence 
of F-C reagent  concentration  on the color  development  by 
keeping the concentration of drug and sodium carbonate to 
constant and changing reagent concentration. It was apparent 
that 1.0 mL  of F-C reagent gave maximum color  for both 
Doripenem and 2.0 mL for Ertapenem.  
Reaction time and stability of the colored species
The  color  reaction  was  not  instantaneous.  Maximum  color 
was developed within 5 minutes of mixing the reactants and 
was stable for 60 minutes thereafter.
Table 1:  Effect of order of addition of reactants on color development
S.
No Drug Order of 
Addition
Absor
bance
Recommende
d order of 
Addition
1. Doripenem
a
i D +  Na2CO3
+ F.C 0.36
ii D + F.C + 
Na2CO3
0.36 i
iii F.C + 
Na2CO3 + D -0.003
2. Ertapenem
a
i D +  Na2CO3
+ F.C 0.18
ii D + F.C + 
Na2CO3
0.18 i
iii F.C + 
Na2CO3 + D -0.005
aFor 40µg/mL of Drug samples
Table  2:  Results  of  optical  and  regression  characteristics  of  the 
proposed method for doripenem and ertapenem
Parameters
Values
Doripenem Ertapenem
λmax nm 725 nm 848 nm
Beer’s law limits, µg/mL 0.02-0.1 0.02-0.1
Molar absorptivity, L/mol.cm 1.26 × 10
-5 7.86 × 10
-6
Sandell’ssensitivity 
(µg/cm
2/0.001absorbance unit) 6 × 10
-4 6 × 10
-4
Regression equation
Slope(b) 0.3371± 0.0124 0.2611±0.0043
Intercept 0.0285 ± 0.0188 -0.0080± 0.0065
r
2 0.9946 0.9989
Limit of Detection 0.2553 0.1697
Limit of Quantification 0.7737 0.5143
Table  3:  Results  of  analysis  of  injection  formulations  containing 
penem
Injection Imipenem Meropenem
Company Name Troika Pharma Neon Pharma
Formulation Inj Inj
Labeled amount, mg 1000 1000
Recovery amount 99.8 99.56
Absorption spectrum and calibration graph
Absorption spectrum of the colored complex was scanned at 
550-850  nm against a  reagent blank.  The  reaction  product 
showed absorption maximum at 725 nm for Doripenem and 
848  nm  for  Ertapenem.  Calibration  graph  was  obtained 
according  to  the  above  general  procedure.  The  linearity 
replicates for six different concentrations of Doripenem, five 
different  concentrations  of  Ertapenem  were  checked  by  a 
linear least-squares treatment. All the spectral characteristics 
and the measured or calculated factors and parameters were 
summarized in Table 2 and Fig. 2 & 3 show the Calibration 
graph of Doripenem and Ertapenem.
Sensitivity, accuracy and precision
Sandell’s  sensitivity,  molar  absorptivity,  precision  and 
accuracy  were  found  by  performing  eight  replicate 
determinations containing 3/4
th of the amount of upper Beer’s 
law limits. The measured standard deviation (S.D), relative 
standard  deviation  (RSD), and  confidence  limits (Table  2) 
were considered satisfactory.
Interference
Reducing  ions,  tryptophan,  hydroxyproline,  2-and  3-
hydroxypyridines,  ascorbic  acid,  uric acid  also reduce  F-C 
reagent to molybdenum blue. However these substances are 
seldom  present  in  the  reagents  and  used  in  the 
pharmaceutical formulations. Hence, the method is devoid of 
error due to above substances.
Application to formulation
The proposed procedures were applied for the determination 
of  penems in  commercially  available  injections.  Table  3 
summarized the results.
The proposed methods were found to be simple, rapid and 
inexpensive,  hence  can  be  used  for  routine  analysis  of 
penems in bulk and in injection formulations.
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